Lipoprotein (a) as a predictor of coronary heart disease: the PRIME Study
- 1 August 2002
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 163 (2) , 377-384
- https://doi.org/10.1016/s0021-9150(02)00026-6
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Apolipoprotein(a) isoforms and coronary heart disease in men: A nested case-control studyAtherosclerosis, 1997
- Ten-year follow-up results from the Goettingen Risk, Incidence and Prevalence Study (GRIPS). I. Risk factors for myocardial infarction in a cohort of 5790 menAtherosclerosis, 1997
- Hypertriglyceridemia and elevated lipoprotein (a) are risk factors for major coronary events in middle-aged menThe American Journal of Cardiology, 1996
- Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS)European Journal of Clinical Investigation, 1994
- Apolipoproteins and ischaemic heart disease: implications for screeningThe Lancet, 1994
- Predictive value of apolipoproteins in a prospective survey of coronary artery disease in menThe American Journal of Cardiology, 1992
- A prospective study of obesity, lipids, apolipoproteins and ischaemic heart disease in womenAtherosclerosis, 1992
- Relation of Serum Lipoprotein(a) Concentration and Apolipoprotein(a) Phenotype to Coronary Heart Disease in Patients with Familial HypercholesterolemiaNew England Journal of Medicine, 1990
- cDNA sequence of human apolipoprotein(a) is homologous to plasminogenNature, 1987
- Methodologic problems and standards in case-control researchJournal of Chronic Diseases, 1979